Suppr超能文献

术后死亡率不能充分反映肺癌切除术的质量。

Postoperative mortality is an inadequate quality indicator for lung cancer resection.

机构信息

Department of Surgery, Division of Thoracic Surgery, University of Virginia Health System, Charlottesville, Virginia.

Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia.

出版信息

Ann Thorac Surg. 2014 Mar;97(3):973-9; discussion 978-9. doi: 10.1016/j.athoracsur.2013.12.016. Epub 2014 Jan 28.

Abstract

BACKGROUND

Postoperative mortality is the most commonly reported surgical quality measure. However, such metrics may be incapable of identifying performance outliers. The purpose of this study was to compare different measures of postoperative mortality after lung cancer resection using a large multiinstitutional database.

METHODS

Data were extracted for lung cancer resection patients from the linked Surveillance Epidemiology and End Results-Medicare Registry (2006 to 2010), which provides detailed and longitudinal information about Medicare beneficiaries with cancer. Four definitions of postoperative mortality were evaluated: in-hospital, 30-day, perioperative, and 90-day. Hierarchical regression models were used to estimate mortality risk at 30 and 90 days, and provider quality was assessed by comparing observed versus expected mortality.

RESULTS

We identified 11,787 lung cancer resection patients from 686 hospitals. The median age was 74 years, and 52% of patients were treated with open lobectomy. Although 30-day, perioperative, and in-hospital mortality rates were between 3% and 4%, 90-day mortality was almost double (6.89%). Clinical variables associated with 90-day mortality included sex, preexisting comorbidities, and procedure type. There were no statistically significant differences in 30-day or 90-day mortality rates among providers.

CONCLUSIONS

Currently reported measures of in-hospital and 30-day postoperative mortality do not adequately represent a patient's true mortality risk as mortality almost doubles by 90 days. Because of low occurrence rate and variable provider volumes, neither 30-day nor 90-day mortality is a suitable quality indicator for lung resection.

摘要

背景

术后死亡率是最常报告的手术质量衡量标准。然而,这些指标可能无法识别绩效异常值。本研究的目的是使用大型多机构数据库比较肺癌切除术后不同的术后死亡率衡量标准。

方法

从链接的监测、流行病学和最终结果-医疗保险登记处(2006 年至 2010 年)中提取肺癌切除术患者的数据,该登记处提供有关癌症的医疗保险受益人的详细和纵向信息。评估了术后死亡率的四种定义:住院期间、30 天、围手术期和 90 天。使用分层回归模型来估计 30 天和 90 天的死亡率风险,并通过比较观察到的死亡率与预期死亡率来评估提供者的质量。

结果

我们从 686 家医院确定了 11787 例肺癌切除术患者。中位年龄为 74 岁,52%的患者接受了开放性肺叶切除术。尽管 30 天、围手术期和住院期间的死亡率在 3%至 4%之间,但 90 天的死亡率几乎翻了一番(6.89%)。与 90 天死亡率相关的临床变量包括性别、预先存在的合并症和手术类型。提供者之间的 30 天或 90 天死亡率没有统计学上的显著差异。

结论

目前报告的住院和 30 天术后死亡率不能充分代表患者的真实死亡率风险,因为 90 天后死亡率几乎增加了一倍。由于发生率低且提供者数量可变,30 天或 90 天死亡率都不是肺切除术的合适质量指标。

相似文献

1
Postoperative mortality is an inadequate quality indicator for lung cancer resection.
Ann Thorac Surg. 2014 Mar;97(3):973-9; discussion 978-9. doi: 10.1016/j.athoracsur.2013.12.016. Epub 2014 Jan 28.
2
Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality.
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2261-2267.e1. doi: 10.1016/j.jtcvs.2014.04.026. Epub 2014 Apr 18.
3
Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality.
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2269-77. doi: 10.1016/j.jtcvs.2014.07.077. Epub 2014 Aug 4.
4
Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2019 Aug;158(2):570-578.e3. doi: 10.1016/j.jtcvs.2019.02.123. Epub 2019 Mar 28.
5
Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population.
J Thorac Cardiovasc Surg. 2012 Jun;143(6):1314-23. doi: 10.1016/j.jtcvs.2011.09.072. Epub 2012 Feb 15.
6
Understanding mortality as a quality indicator after esophagectomy.
Ann Thorac Surg. 2014 Aug;98(2):506-11; discussion 511-2. doi: 10.1016/j.athoracsur.2014.03.041. Epub 2014 May 17.
7
Ninety-Day Mortality: Redefining the Perioperative Period After Lung Resection.
Clin Lung Cancer. 2021 Jul;22(4):e642-e645. doi: 10.1016/j.cllc.2020.12.011. Epub 2020 Dec 26.
8
Performance indicators for lung cancer surgery in the Netherlands.
Eur J Cardiothorac Surg. 2015 May;47(5):897-903; discussion 903-4. doi: 10.1093/ejcts/ezu329. Epub 2014 Sep 3.
9
Failure to rescue and pulmonary resection for lung cancer.
J Thorac Cardiovasc Surg. 2015 May;149(5):1365-71; discussion 1371-3.e3. doi: 10.1016/j.jtcvs.2015.01.063. Epub 2015 Feb 11.
10
The relationship between hospital lung cancer resection volume and patient mortality risk.
Ann Surg. 2011 Dec;254(6):1032-7. doi: 10.1097/SLA.0b013e31821d4bdd.

引用本文的文献

2
The Effect of Timeliness of Care on Lung Cancer Survival - A Population-Based Approach.
Ann Glob Health. 2023 Jun 5;89(1):39. doi: 10.5334/aogh.3845. eCollection 2023.
3
Video-assisted thoracoscopic lobectomy and bilobectomy versus open thoracotomy for non-small cell lung cancer: Mortality and survival.
Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jan 28;30(1):66-74. doi: 10.5606/tgkdc.dergisi.2022.20912. eCollection 2022 Jan.
4
Quality indicators in lung cancer: a review and analysis.
BMJ Open Qual. 2021 Aug;10(3). doi: 10.1136/bmjoq-2020-001268.
5
The risk factors for treatment-related mortality within first three months after kidney transplantation.
PLoS One. 2020 Dec 10;15(12):e0243586. doi: 10.1371/journal.pone.0243586. eCollection 2020.
6
The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort study.
PLoS One. 2020 Jul 28;15(7):e0236274. doi: 10.1371/journal.pone.0236274. eCollection 2020.
7
Stage I lung cancer-to operate or to radiate? that is the question.
J Thorac Dis. 2016 Sep;8(9):2324-2327. doi: 10.21037/jtd.2016.08.36.
8
Readmission predicts 90-day mortality after esophagectomy: Analysis of Surveillance, Epidemiology, and End Results Registry linked to Medicare outcomes.
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1254-60. doi: 10.1016/j.jtcvs.2015.08.071. Epub 2015 Aug 28.
9
Improving lung cancer outcomes by improving the quality of surgical care.
Transl Lung Cancer Res. 2015 Aug;4(4):424-31. doi: 10.3978/j.issn.2218-6751.2015.08.01.
10
Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality.
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2261-2267.e1. doi: 10.1016/j.jtcvs.2014.04.026. Epub 2014 Apr 18.

本文引用的文献

1
Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population.
J Thorac Cardiovasc Surg. 2012 Jun;143(6):1314-23. doi: 10.1016/j.jtcvs.2011.09.072. Epub 2012 Feb 15.
2
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.
HPB (Oxford). 2011 Jul;13(7):473-82. doi: 10.1111/j.1477-2574.2011.00326.x. Epub 2011 May 18.
3
The relationship between hospital lung cancer resection volume and patient mortality risk.
Ann Surg. 2011 Dec;254(6):1032-7. doi: 10.1097/SLA.0b013e31821d4bdd.
4
The effect of regionalization on outcome in pulmonary lobectomy: a Canadian national study.
J Thorac Cardiovasc Surg. 2010 Oct;140(4):757-63. doi: 10.1016/j.jtcvs.2010.06.040.
5
Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database.
Ann Thorac Surg. 2010 Sep;90(3):927-34; discussion 934-5. doi: 10.1016/j.athoracsur.2010.05.041.
6
STS database risk models: predictors of mortality and major morbidity for lung cancer resection.
Ann Thorac Surg. 2010 Sep;90(3):875-81; discussion 881-3. doi: 10.1016/j.athoracsur.2010.03.115.
7
The 30- versus 90-day operative mortality after pulmonary resection.
Ann Thorac Surg. 2010 Jun;89(6):1717-22; discussion 1722-3. doi: 10.1016/j.athoracsur.2010.01.069.
8
Is VATS lobectomy better: perioperatively, biologically and oncologically?
Ann Thorac Surg. 2010 Jun;89(6):S2107-11. doi: 10.1016/j.athoracsur.2010.03.020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验